We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.71%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$786M
AUM Growth
+$437M
(+125%)
Cap. Flow
+$384M
Cap. Flow
% of AUM
48.81%
Top 10 Holdings %
Top 10 Hldgs %
60.73%
Holding
976
New
432
Increased
206
Reduced
50
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$67.9M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$40.6M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$23.8M |
| 4 |
EFOR
Everforth Inc
EFOR
|
+$22.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.07M |
| 2 |
UroGen Pharma
URGN
|
+$1.67M |
| 3 |
PayPal
PYPL
|
+$752K |
| 4 |
Allogene Therapeutics
ALLO
|
+$713K |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
+$682K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.68% |
| 2 | Technology | 11.41% |
| 3 | Consumer Discretionary | 7.86% |
| 4 | Industrials | 4.27% |
| 5 | Communication Services | 4.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Best Buy
BBY
$17.3B
| $13K | ﹤0.01% |
177
| – | – |
|
477
Core Laboratories
CLB
$521M
| $13K | ﹤0.01% |
191
| – | – |
|
478
ConocoPhillips
COP
$141B
| $13K | ﹤0.01% |
201
-1,128
| -85% | -$75.9K |
|
479
Qorvo
QRVO
$8.74B
| $13K | ﹤0.01% |
177
| – | – |
|
480
iShares MSCI USA Quality Factor ETF
QUAL
$47.9B
| $13K | ﹤0.01% |
+145
| New | +$12.2K |
|
481
Vodafone
VOD
$37.4B
| $13K | ﹤0.01% |
+718
| New | +$13.3K |
|
482
AutoZone
AZO
$51.1B
| $12K | ﹤0.01% |
+12
| New | +$10.8K |
|
483
Bausch Health
BHC
$2.34B
| $12K | ﹤0.01% |
+500
| New | +$11.9K |
|
484
Camtek
CAMT
$7.25B
| $12K | ﹤0.01% |
1,400
| – | – |
|
485
Canadian National Railway
CNI
$76.6B
| $12K | ﹤0.01% |
+134
| New | +$11.2K |
|
486
Deutsche Bank
DB
$71.5B
| $12K | ﹤0.01% |
+1,433
| New | +$12.6K |
|
487
First American
FAF
$7.58B
| $12K | ﹤0.01% |
228
+2
| +0.9% | +$99 |
|
488
Flowers Foods
FLO
$1.57B
| $12K | ﹤0.01% |
585
+5
| +0.9% | +$100 |
|
489
Ionis Pharmaceuticals
IONS
$9.4B
| $12K | ﹤0.01% |
146
| – | – |
|
490
JPMorgan US Value Factor ETF
JVAL
$865M
| $12K | ﹤0.01% |
+445
| New | +$11.3K |
|
491
Medtronic
MDT
$112B
| $12K | ﹤0.01% |
140
-2,001
| -93% | -$179K |
|
492
Markel Group
MKL
$23.2B
| $12K | ﹤0.01% |
+12
| New | +$12.2K |
|
493
Old Dominion Freight Line
ODFL
$44.9B
| $12K | ﹤0.01% |
255
| – | – |
|
494
PVH
PVH
$4.04B
| $12K | ﹤0.01% |
+112
| New | +$12.3K |
|
495
Trex
TREX
$5.01B
| $12K | ﹤0.01% |
388
| – | – |
|
496
Vanguard Information Technology ETF
VGT
$149B
| $12K | ﹤0.01% |
488
| – | – |
|
|
CLDR
497
DELISTED
Cloudera, Inc.
CLDR
| $12K | ﹤0.01% |
1,133
+387
| +52% | +$4.97K |
|
498
ARK Web x.0 ETF
ARKW
$1.76B
| $11K | ﹤0.01% |
215
| – | – |
|
499
BGSF Inc
BGSF
$60M
| $11K | ﹤0.01% |
511
+6
| +1% | +$144 |
|
500
Cognex
CGNX
$11.3B
| $11K | ﹤0.01% |
218
| – | – |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q1 2019 Portfolio in Review
As of Q1 2019, Pathstone Family Office held 976 positions worth $786M, up 125% from $349M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Pathstone Family Office deployed $384M of net new capital in Q1 2019, opening 432 new positions and adding to 206 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 232,515 shares worth $12M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $2.07M trimmed.
- Pathstone Family Office's largest Q1 2019 buy was iShares Core MSCI Emerging Markets ETF: 232,515 shares worth $12M.
- Pathstone Family Office added most to Vanguard Morningstar Total Stock Market ETF in Q1 2019, an estimated $67.9M increase.
- Pathstone Family Office's biggest Q1 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.07M.
- Pathstone Family Office fully exited UroGen Pharma in Q1 2019, selling an estimated $1.67M.
- Pathstone Family Office's ten largest holdings make up 61% of its $786M portfolio in Q1 2019.
- Pathstone Family Office opened 432 new positions and closed 63 in Q1 2019.
- Pathstone Family Office's portfolio value rose 125% quarter-over-quarter to $786M.
Based on Pathstone Family Office's 13F filing for Q1 2019, filed 14 May 2019.